The University of Iowa Pharmaceuticals (UIP) has been developing formulations for various pharmaceutical dosage forms for over 40 years. In addition UIP' internal formulation development capabilities, UIP has access to UIPDC (The University of Iowa Pharmaceuticals Development Consortium) which is made up of University of Iowa College of Pharmacy pharmaceutics faculty. This unit’s focus is formulation development, especially for compounds that present scientific challenges (solubility, stability, etc.).
- Examples of formulations which have been developed include standard immediate release solid oral dosage forms; sterile solutions and lyophilized powders; oral solutions and suspensions; and topical creams, gels, and ointments; sustained release tablets produced using coating technology or hydrophilic matrixes; enteric coated tablets and capsules; and hot-melt filled capsules.
- UIP has extensive experience using roller compaction, fluid bed granulation, and traditional wet granulation techniques to formulate solid oral dosage forms.
- Once a formulation has been developed and test batches of finished dosage forms produced UIP has the capability to develop and validate analytical methods to perform analytical testing on the finished dosage forms to assure their quality and stability and allow the production of clinical supplies.
- UIP also has the capability to begin range finding studies as a starting point for subsequent process and formulation validation studies.
For more information about our formulation development services please consult the UIPDC page and/or Contact Us.